Billionaire investor Bill Ackman acquired an approximate 8.5 percent stake in
Zoetis Inc (NYSE: ZTS), a producer of animal
medicines and vaccinations, back in November 2014.
Ackman and his hedge fund Pershing Square Capital Management first bought 5.5 million shares of Zoetis in 2014 at $34 per share
and added to his position over the years. The
New York Times reported in May of this year that Ackman was looking to sell its entire 16.85 million share stake in Zoetis for
a price range of $46.75 to $47 per share or a total consideration of around $800 million.
The New York times also noted that Ackman paid $1.5 billion for the entire stake of Zoetis.
Zoetis' stock was trading at $51.02 on Thursday.
Pershing Eliminates Its Stake
Pershing Square confirmed
with Benzinga on Thursday that Ackman announced during the fund's quarterly investor call that it completed sold its stake in
Zoetis.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.